UK invests to streamline manufacture of next-gen medicine
Funding of £7.3m will be provided across three initiatives, with the long-term aim of providing patients with access to cell and gene therapies at a faster rate.
Archives for November 23, 2018
US FDA approves first HLH treatment in 24 years
Sobi’s Gamifant is approved as a treatment for pediatric and adult patients with primary hemophagocytic lymphohistiocytosis.
WuXi Biologics announces new discovery, development and manufacturing site in China
The CDMO has broken ground on its 1.6 million-square-foot Biologics Innovation Center in Shanghai.